{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:42:33Z","timestamp":1747154553471,"version":"3.40.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ajg.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T21:46:23Z","timestamp":1429652783000},"page":"40-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literature"],"prefix":"10.1016","volume":"16","author":[{"given":"Mona","family":"Fouad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajg.2015.03.003_b0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transproceed.2012.07.151","article-title":"Transplantation for hepatocellular carcinoma in younger patients has an equivocal survival advantage as compared with resection","volume":"45","author":"Graham","year":"2013","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.ajg.2015.03.003_b0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4149\/av_2012_03_235","article-title":"Hepatitis C virus and other risk factors in hepatocellular carcinoma","volume":"56","author":"Schiefelbein","year":"2012","journal-title":"Acta Virol"},{"issue":"42","key":"10.1016\/j.ajg.2015.03.003_b0015","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.3748\/wjg.14.6437","article-title":"Evolution of systemic therapy of advanced hepatocellular carcinoma","volume":"14","author":"Yau","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2015.03.003_b0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","article-title":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization","volume":"37","author":"Raoul","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ajg.2015.03.003_b0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment; Study of 850 patients","volume":"56","author":"Okuda","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ajg.2015.03.003_b0030","unstructured":"AJCC staging system 7th edition, 2011, www.cancerstaging.org, accessed on 28\/5\/2013."},{"issue":"6","key":"10.1016\/j.ajg.2015.03.003_b0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.50.6.881","article-title":"Liver Cancer Study Group of the University of Toronto., Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto","volume":"50","author":"Levy","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ajg.2015.03.003_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.critrevonc.2006.06.001","article-title":"Treatment of hepatocellular carcinoma","volume":"60","author":"Forner","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ajg.2015.03.003_b0045","article-title":"American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma; an update","author":"Bruix","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ajg.2015.03.003_b0050","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1007\/s10620-013-2872-x","article-title":"Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: a systematic review of the literature","volume":"58","author":"Abdel-Rahman","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.ajg.2015.03.003_b0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jnci.2013.08.003","article-title":"Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience","volume":"26","author":"Abdel-Rahman","year":"2014","journal-title":"J Egypt Nat Cancer Inst"},{"issue":"4","key":"10.1016\/j.ajg.2015.03.003_b0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/liv.12112","article-title":"Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma","volume":"33","author":"Lao","year":"2013","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.ajg.2015.03.003_b0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jvir.2011.11.012","article-title":"Transarterial chemoembolizationfor hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues","volume":"23","author":"Toyoda","year":"2012","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"10.1016\/j.ajg.2015.03.003_b0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1440-1746.2009.05863.x","article-title":"Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma","volume":"24","author":"Li","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2015.03.003_b0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hep.21024","article-title":"A randomised controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization","volume":"43","author":"Jang","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.ajg.2015.03.003_b0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jnci.2013.08.002","article-title":"Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside","volume":"25","author":"Abdel-Rahman","year":"2013","journal-title":"J Egypt Nat Cancer Inst"},{"year":"2013","series-title":"Exploring Systemic Options for Advanced Hepatocellular Carcinoma","author":"Abdel-Rahman","key":"10.1016\/j.ajg.2015.03.003_b0085"},{"issue":"3","key":"10.1016\/j.ajg.2015.03.003_b0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12032-013-0655-z","article-title":"Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma","volume":"30","author":"Abdel-Rahman","year":"2013","journal-title":"Med Oncol"},{"issue":"37","key":"10.1016\/j.ajg.2015.03.003_b0095","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3748\/wjg.v19.i37.6214","article-title":"Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt","volume":"19","author":"Elkady","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajg.2015.03.003_b0100","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study, Taiwan Cooperative Oncology Group","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2015.03.003_b0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajg.2015.03.003_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2013.12.013","article-title":"Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma; a systematic review of the literature","volume":"91","author":"Abdel-Rahman","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ajg.2015.03.003_b0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14737140.2015.1014342","article-title":"Risk of mucocutaneous toxicities in solid tumor patients treated with sorafenib; an updated systematic review and meta analysis","volume":"15","author":"Abdel-Rahman","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"8","key":"10.1016\/j.ajg.2015.03.003_b0120","first-page":"460","article-title":"Therapeutic effect and prognosis of interferon therapy after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma associated with hepatitis B virus","volume":"12","author":"Gao","year":"2004","journal-title":"Zhonghua Gan Zang Bing Za Zhi."}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197915000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197915000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T04:24:41Z","timestamp":1537676681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197915000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1687197915000106"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2015.03.003","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of transarterial chemoembolisation (TACE) plus antivirals for the management of hepatitis B-related hepatocellular carcinoma: A systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Arab Journal of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}